There's probably a list.
Certainly the funding cycles that we've faced have made it difficult to roll out support on an annual basis. That's been an ongoing problem.
There are regulatory issues at Health Canada. We're working with all of the stakeholders and Health Canada to help move that along.
We would like to enhance the commercialization of some of our discoveries, but because of our funding agreement, we can't support research in companies. These are very small companies. We have to support the academic aspects.
What else is there?